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ABSTRACT
Objective: The role of  sleep architecture in consolidation of  memory has not been extensively 
investigated. In this study, the association of  continuous positive airway pressure (CPAP) and sleep 
architecture and quality, and sleep disordered breathing on changes in memory are explored during 
the course of  a 6 month clinical trial of  CPAP or sham CPAP (APPLES). Methods: 848 participants 
had polysomnographic and memory assessments (Buschke Selective Reminding Test [Buschke] and 
Digit Symbol Substitution Test [DSST]) at baseline, CPAP/Sham CPAP titration, and the 2 and 6 
month time points. Half  were assigned to the CPAP and Sham CPAP groups respectively. Changes 
in performance on the Buschke and the DSST were analyzed over the course of  the study between 
CPAP and Sham CPAP as well as in relationship to changes in sleep architecture, sleep quality and 
sleep disordered breathing (SDB). Results: Sleep architecture, sleep quality and SDB improved in 
the CPAP group at 6 months; performance on the Buschke and DSST improved equally in both 
CPAP and Sham CPAP groups. There also were no significant correlations between changes in 
the amount or percentage of  sleep stages between baseline and the 6 months, and corresponding 
changes in either the Buschke or the DSST. However, when stratified by the upper quartile and 
lower 3 quartiles, greater changes in the Buschke occurred over 6 months in the top quartile of  
total sleep time (5.7±7.3 vs. 4.0±6.8, p≤0.01) and amount of  N3 sleep (55.9±7.7 vs. 53.6±8.9 
min, p≤0.01). Those with more %N3 at 6 months scored better on the Buschke as well (55.9±7.8 
vs. 53.6±8.9, p≤0.01). Borderline improvement in the DSST over 6 months was observed in the 
top quartiles of  amount of  N3 and %N3. Those in the top quartile of  the amount of  REM and 
%REM also showed greater improvement in the Buschke after 6 months. No differences were 
observed for the AHI, but those in the top quartile of  oxygen desaturation had worse scores on 
the Buschke at 6 months. CPAP/Sham CPAP adherence did not impact 6 month Buschke or DSST 
performance. Conclusions: CPAP improved long-term sleep duration, quality and architecture, 
but did not memory. However, large changes in REM and N3 sleep as well as moderate amounts of  
nocturnal hypoxemia are associated with changes in assessments of  memory.
Keywords: Sleep; Obstructive Sleep Apnea Syndrome; Memory; Continuous Positive Airway 
Pressure.
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INTRODUCTION
There is general consensus that retention of  memories 
occurs through a two-step process in which sleep plays an es-
sential role for optimum performance. Initially, new informa-
tion is encoded into temporary storage. Subsequently, some of  
this information is consolidated into long-term storage where 
it can be recalled when needed1. Sleep has been identified as a 
critical component for this latter activity to occur2. However, the 
role that various sleep stages play in this process appear to dif-
fer. Substantial evidence points to the importance of  neuronal 
activity in the hippocampus during slow wave sleep (SWS) in 
strengthening declarative memory3. In contrast, rapid eye move-
ment (REM) sleep may be important in enhancing procedural 
learning as well as for contextual and spatial memory consolida-
tion4.
Obstructive sleep apnea (OSA) is often characterized by 
neurocognitive deficits including impairment in memory5. Some, 
but not all studies have demonstrated that memory improves 
after OSA treatment with continuous positive airway pressure 
(CPAP)6-10. Whether improvement in memory after treatment 
with CPAP is correlated with changes in sleep architecture is 
unclear and has not been extensively studied2. 
The Apnea Positive Pressure Long-term Efficacy Study 
(APPLES) was a 6 month randomized sham-controlled study 
of  the impact of  CPAP on various neurocognitive domains in 
patients with OSA. Polysomnograms and neurocognitive as-
sessments were performed before and after intervention with 
CPAP or sham CPAP11. Thus, the study provides a vehicle for 
studying whether changes in memory are associated with cor-
responding changes in sleep architecture. It is hypothesized that 
improvement in memory occurs with CPAP and that it is associ-
ated with increases in REM sleep and SWS.
METHODS
participants and study design
The study design, recruitment procedures, and inclu-
sion and exclusion criteria for APPLES have been described 
extensively11. The institutional review board (IRB) at each site 
approved the study protocol and the study was registered at 
ClinTrials.gov (NCT00051363). Briefly, APPLES was a multi-
site study conducted at 5 clinical centers: Stanford University, 
Stanford, CA; University of  Arizona, Tucson, AZ; Providence 
St. Mary Medical Center, Walla Walla, WA; St. Luke’s Hospital, 
Chesterfield, MO; and Brigham and Women’s Hospital, Boston, 
MA. Participants were recruited into the study primarily from 
patients scheduled into a regular sleep clinic for evaluation of  
possible OSA, and from local advertising. Recruitment began in 
November 2003 and was completed in August 2008. 
Initial enrollment required age > 18 years and clini-
cal symptoms of  OSA, as defined by American Academy of  
Sleep Medicine (AASM) criteria12. At enrollment, participants 
underwent a screening diagnostic polysomnogram (PSG) and 
baseline neurocognitive testing including the standardized as-
sessments described below. Only participants with an apnea hy-
popnea index (AHI) > 10 events per hour continued to the clini-
cal trial and were randomized subsequently to sham or active 
CPAP for 6 months as previously reported13. Those participants 
had a CPAP or sham CPAP titration polysomnogram and sub-
sequently had a repeat polysomnogram on their assigned treat-
ment 2 and 6 months later. 
Excluded were individuals who had 1) prior OSA treat-
ment with CPAP or surgery, 2) household members with cur-
rent/past CPAP use, 3) a sleepiness-related automobile accident 
within the year prior to potential enrollment, (4) oxygen satu-
rations < 75% for > 10% of  the diagnostic polysomnogram 
(PSG) total sleep time; or (5) conditions or use of  medications 
that could potentially affect neurocognitive function and/or 
alertness. For the present analysis, only data from randomized 
participants who had polysomnography and neurocognitive 
testing at the baseline, 2 and 6 month time points were used. 
Some of  the material related to sleepiness and neurocognitive 
testing reported herein represent reanalysis of  data in a differ-
ent format from what has been published in a previous paper9.
POLYSOMNOGRAPHY
Polysomnography was conducted as previously de-
scribed using signals from a nasal pressure cannula, nasal/oral 
thermistor, thoracic and abdominal piezo bands, and a pulse 
oximeter to classify apnea and hypopnea events11. An apnea was 
identified by a > 90% amplitude decrease from baseline of  the 
nasal pressure signal lasting > 10 sec. Hypopneas were scored if  
there was a > 50%, but < 90% decrease from baseline of  the na-
sal pressure signal, or if  there was a clear amplitude reduction of  
the nasal pressure signal that did not reach the above criterion 
but it was associated with either an oxygen desaturation ≥ 3% or 
an arousal, and the event duration was ≥ 10 seconds. 
Obstructive apneas were identified by persistence of  
chest or abdominal respiratory effort during flow cessation. 
Central apneas were noted if  no displacement occurred on ei-
ther the thoracic or abdominal channels. The severity of  OSA 
was expressed using the apnea hypopnea index (number of  ap-
neas + hypopneas/total sleep time, AHI). Magnitude of  oxygen 
desaturation was indicated by the % of  the total sleep time less 
than 85% (O2LT85%). All studies were scored at the central 
reading center located at Stanford University.
CPAP ADHERENCE
Adherence to CPAP or sham CPAP was measured 
objectively using Encore Pro SmartCards (Phillips Respiron-
ics, Inc., Murrysville, PA) that were returned by the partici-
pant twice monthly. For this report, the mean hours of  daily 
use were analyzed for the preceding 1-month period before 
the 2- and 6-month study visits.
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Assessment of  Sleepiness
Epworth Sleepiness Scale (ESS)
The ESS is a validated self-administered questionnaire 
that asks an individual to rate his or her probability of  falling 
asleep on a scale of  increasing probability from 0 to 3 in 8 dif-
ferent situations14. The scores for the 8 questions are summed 
to obtain a single score from 0 to 24 that is indicative of  self-
reported sleep propensity. The ESS prior to randomization was 
administered at the time of  the clinical evaluation and on the 
night of  the diagnostic PSG. For a baseline, the value at the time 
of  the diagnostic PSG was used, but if  not available, then the 
value at the time of  the clinical evaluation was substituted.
Assessments of  Learning and Memory
Buschke Selective Reminding Test (Buschke)
The Buschke is an assessment of  verbal learning and 
memory15. The version used in APPLES consisted of  a list of  
12 unrelated verbally presented words which the participant 
was asked to recall on successive trials. Non-recalled words on 
6 successive trials were selectively re-presented or until the par-
ticipant recalled the entire list on 3 consecutive trials. A delayed 
recall trial with forewarning was administered 30 minutes later. 
The sum recall (total number of  word recalled over 6 trials) was 
used in these primary analyses.
Digit Symbol Substitution Test (DSST)
The CogScreen analogue of the DSST was used in APPLES16. 
The DSST evaluates sustained attention, visual scanning, information 
processing speed, immediate and delayed visual paired-associate mem-
ory and working memory. The participant is asked to match numbers 
(1-9) to their corresponding hieroglyphic-like symbol, and type them 
on a keyboard as quickly as possible within a 90-second time frame. 
The percent correct was used for these analyses. 
STATISTICAL ANALYSES
Inasmuch as this was a subgroup analysis, outcome 
variables were defined post hoc based on our initial hypotheses 
pertaining to the impact of  CPAP on memory and preliminary 
exploration of  the data. Changes in outcome variables over time 
were analyzed using a mixed model repeated measures analysis 
of  variance with participants stratified by their randomization 
group (CPAP or Sham CPAP). Groups differences were deter-
mined using analysis of  variance or Student’s t test as appropri-
ate. Associations between variables were assessed by calculating 
Pearson correlation coefficients. Data are expressed as mean + 
standard deviation (SD) or percentages. P<0.05 was considered 
statistically significant. Analyses were performed using IBM 
SPSS Statistics Version 24 (Chicago, IL).
RESULTS
As shown in Table 1, of the 1104 participants ran-
domized at baseline, there were 848 who had polysom-
nographic, Buschke and DSST data at baseline, CPAP/
Sham CPAP titration, and the 2 and 6 month time 
Table 1. Baseline Demographic Information.
N %
Total Participants 848
% Men 552 65.1
Ethnicity
Non Hispanic White 647 76.3
Black 75 8.8
Hispanic 60 7.1
Asian 50 5.9
Native American 13 1.5
Other 3 0.4
Age 52±12 years
Body Mass Index (kg/m2) 32.2±7.1
Apnea Hypopnea Index (#/hour) 40.7±24.9
% Time Oxygen Saturations < 85% 2.2±6.2
Group Assignment
Sham 406 47.9
CPAP 442 52.1
Compliance with CPAP/Sham 
CPAP at 6 months, Hours)
Sham 354 3.5±2.3
CPAP 403 4.5±2.3
points. There were 442 assigned to CPAP and 406 as-
signed to Sham CPAP. Approximately 66% were men, 
and most were non Hispanic white. Their mean age was 
52±12 years with a BMI of 32.2±7.1 kg/m2. Overall, par-
ticipants had severe OSA with a mean AHI of 40.7±24.9 
/hour. There were no differences in OSA severity be-
tween groups (results not shown).
Changes in sleep and sleep architecture are dis-
played in Table 2. Total sleep time, sleep efficiency and 
arousal index improved immediately with use of CPAP 
in comparison to Sham CPAP. In addition, the absolute 
amount and % of N1 sleep decreased with a correspond-
ing increase in the absolute amount and % of the remain-
ing sleep stages. These changes in sleep duration, quality 
and architecture were generally maintained over the entire 
6 month length of the study. In addition, improvements 
in sleep architecture correlated with better adherence to 
CPAP. No associations with adherence were observed in 
the Sham CPAP group (results not shown).
In Table 3 is presented the changes in the Busch-
ke, DSST, ESS, AHI and O2LT85% over the course of the 
study. Scores on the Buschke and the DSST improved at 
the 2 and 6 month time points, but did so in the CPAP 
and Sham CPAP groups equally. In contrast, the ESS, 
AHI and O2LT85% were abnormally high at baseline, 
and had decreased at 2 and 6 months with CPAP. No 
changes over 6 months were observed in the Sham 
CPAP group. 
After combining both groups, there were no sig-
nificant correlations between changes in the amount or 
percentage of sleep stages between baseline and the 6 
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Table 2. Changes in Sleep and Sleep Architecture after Sham or CPAP.
Diagnostic CPAP 2 Months 6 Months
Total Sleep Time (TST)
Sham 375.9±63.2 346.2±71.5 391.6±62.7 389.8±59.5
CPAP 376.1 ± 66.7 358.7±72.3† 395.5±61.7 397.8±61.2‡
Sleep Efficiency (%TST)
Sham 78.0±12.2 75.4±13.5 81.7±11.6 81.3±11.6
CPAP 78.4±13.3 77.6±13.5† 82.0±11.7 82.8±12.3*
Arousal Index (#/h)
Sham 30.4±21.9 32.3±19.7 30.5±20.1 30.0±20.5
CPAP 29.1±18.9 16.2±11.8§ 15.5±10.3§ 16.1±11.5§
N1 Sleep (Min)
Sham 71.5±55.2 67.3±49.3 66.7±51.7 68.0±56.3
CPAP 66.9±49.8 43.3±30.1§ 49.3±33.4§ 46.5±31.0§
N1 Sleep (% TST)
Sham 19.5±14.9 20.5±16.0 17.8±14.6 18.1±15.4
CPAP 18.5±14.3 12.4±8.4§ 12.8±9.1§ 12.1±8.5§
N2 Sleep (Min)
Sham 227.0±67.7 214.8±70.7 237.5±70.2 236.5±66.1
CPAP 229.0±66.1 227.0±56.4‡ 250.0±57.3‡ 253.3±52.6§
N2 Sleep (%TST)
Sham 60.2±14.4 61.4±15.1 60.2±14.0 60.5±13.8
CPAP 60.9±13.5 63.6±10.6‡ 63.1±10.4§ 63.7±9.0§
N3 Sleep (Min)
Sham 11.4±22.2 11.7±22.3 13.1±23.3 11.7±22.2
CPAP 11.1±20.3 16.6±26.1‡ 15.2±26.7 14.8±26.1*
N3 Sleep (%TST)
Sham 3.0±5.8 3.4±6.5 3.3±5.8 2.8±5.2
CPAP 2.9±5.2 4.6±7.1† 3.8±6.7 3.6±6.3†
REM Sleep (Min)
Sham 65.4±29.2 51.9±27.5 73.3±30.9 73.2±31.4
CPAP 67.5±30.4 71.2±33.2§ 80.5±31.2‡ 82.7±33.5§
REM Sleep (%)
Sham 17.3±7.1 14.6±6.9 18.5±7.1 18.5±7.0
CPAP 17.5±6.9 19.3±7.7† 20.2±6.8‡ 20.4±7.3†
*p<0.1 vs. Sham
†p<.05 vs. Sham
‡p<.01 vs. Sham
§p<.001 vs. Sham
month time point, and corresponding changes in either 
the Buschke or the DSST. In addition, there was no cor-
relation between 6 month CPAP/Sham CPAP adher-
ence at the 6 month time point, and changes in either 
the Buschke or the DSST (results for both analyses not 
shown). To explore whether there was a threshold for 
the amount of change in sleep, sleep architecture, sleep 
related breathing, and CPAP/Sham CPAP adherence 
variables necessary to be associated with changes in the 
Buschke and DSST, the distributions of these variables 
were divided into their top quartile and bottom 3 quar-
tiles. 
In Table 4 is shown the comparison between 
these 2 groups in their 6 month Buschke and DSST 
scores and their change over 6 months. Although there 
were few significant differences, greater changes in the 
Buschke occurred over 6 months in those participants 
in the top quartile of total sleep time (5.7±7.3 vs. 4.0±6.8, 
p≤0.01). Similarly, those in the top quartile of amount 
of N3 sleep (55.9±7.7 vs. 53.6±8.9 min, p≤0.01) and %N3 
(55.9±7.8 vs. 53.6±8.9, p≤0.01) at 6 months scored better 
on the Buschke. In parallel, greater improvement in the 
DSST over 6 months was observed in the top quartiles 
of amount of N3 and %N3 distribution although they 
were only of borderline statistical significance. Those 
in the top quartile of the amount of REM and %REM 
also showed greater improvement in the Buschke after 6 
months. No differences were observed for the AHI, but 
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Table 3. Change in Buschke, Digit Symbol Sum Recall and Epworth Sleepiness Scale After Sham or CPAP.
Change
Diagnostic 2 Month 6 Month 6 Month-Diagnostic
Buschke Sum Recall
Sham 49.8±8.9 52.2±8.8 54.3±8.7 4.6±7.1
CPAP 49.7±9.1 52.4±8.6 54.1±8.7 4.3±6.9
Digit Sum Recall
Sham 46.6±26.5 53.7±28.4 55.5±28.1 9.2±27.8
CPAP 44.6±26.9 54.0±27.7 53.7±28.8 8.6±28.3
Epworth Sleepiness Scale*
Sham 10.2±4.6 8.5±4.8 8.3±4.6 -1.7±3.4
CPAP 10.0±4.3 7.1±4.8† 6.8±4.6† -2.8±4.1†
Apnea Hypopnea Index
Sham 41.2±25.2 31.5±25.5 30.5±25.2 10.9±21.3
CPAP 40.2±24.4 6.2±7.7† 6.4±8.5† 34.0±24.2†
% Time Oxygen Saturations < 85%
Sham 2.2±6.0 2.8±8.0 2.3±7.1  0.1±6.4
CPAP 2.3±6.4 0.2±1.0† 0.3±2.3† -2.0±6.4†
*Adjusted for 6 month adherence
†p<.001 vs. Sham
those in the top quartile of O2LT85% had worse scores 
on the Buschke at 6 months. There was no impact of 
overall CPAP or sham CPAP adherence on the Buschke 
or the DSST at 6 months or their change over 6 months. 
Stratification by treatment group also found no differ-
ences (results not shown).
DISCUSSION
In this analysis, after intervention with CPAP or Sham 
CPAP, sleep architecture and sleep quality improved immedi-
ately with CPAP, but not Sham CPAP, and these changes were 
maintained over the 6 months of  the trial. In contrast, memory 
assessed by the Buschke and DSST improved to the same de-
gree with both CPAP and Sham CPAP. Furthermore, changes 
in sleep, sleep architecture or indices of  sleep-related breathing 
disorder from baseline to 6 months did not correlate with cor-
responding changes in memory. However, those participants in 
the highest quartile of  change in REM sleep and SWS had great-
er improvements in memory than those in the lower quartiles; 
those in the top quartile of  O2LT85% had worse scores on the 
Buschke. These observations support the contention that both 
REM sleep and SWS are important in the retention of  memo-
ries and suggest that oxygen desaturation may be detrimental.
In the CPAP group, sleep duration and sleep quality as 
well as indices of  sleep-related breathing disorder improved after 
this intervention; these changes were maintained for 6 months. 
Although these observations were expected17-20, not all stud-
ies have found that CPAP improves sleep quality21, and similar 
results from previous investigations were of  shorter duration. 
Improvement in sleep architecture was correlated with CPAP 
adherence further strengthening a causal relationship. Thus, our 
results extend previous findings by objectively confirming that 
improvements in sleep and sleep quality resulting from CPAP 
are maintained in the long-term.
Our finding that CPAP did not improve performance 
on the Buschke has been reported in previous publications 
documenting the results from APPLES9,22; we now extend this 
finding to the DSST. The absence of  a difference between the 
2 groups could be a function of  the low level of  compliance 
among the CPAP users and/or the very low level of  positive 
pressure inherent with Sham CPAP. However, we did not find 
any impact of  CPAP compliance on Buschke or DSST perfor-
mance which argues against the former explanation. In both the 
CPAP and Sham CPAP groups, performance on both of  these 
memory tasks improved to the same extent thus indicating a 
substantial practice/learning effect. Future studies using either 
of  these assessments need to account for this observation. 
We did not observe that changes in sleep variables from 
baseline to 6 months corresponded to changes in either the 
Buschke or DSST. However, we did find that when analyses 
were focused on differences between more extreme changes in 
sleep variables, in particular, REM sleep and SWS, there was 
an impact on memory. As reviewed by Diekelmann and Born, 
reactivation of  encoded memories during SWS strengthen them 
in the hippocampus and facilitate their transfer into neocortical 
and striatal networks23.
Thus, our findings that participants who had the largest 
increases in the amount and percentage of  N3 sleep had better 
performance on the Buschke and DSST support this construct. 
Similarly, there is substantial evidence that REM sleep plays 
an important role in consolidation of  procedural memory as 
well as declarative memories that are spatially complex or emo-
tional4. Although neither the Buschke nor DSST are tasks that 
specifically evaluate these latter components of  memory, we did 
observe trends for better performance in those participants who 
had the greatest changes in the amount and percentage of  REM. 
With respect to sleep disordered breathing, analyses 
noted that greater time spent with oxygen saturations less than 
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Buschke Selective Reminding Test Sum Recall Symbol Digit Coding Delay Recall Task
N Six Month Score N
Change in Score: 6 
Month - Baseline
N Six Month Score N
Change in Score: 6 
Month - Baseline
Total Sleep Time (Min)
Top Quartile 212 54.4±8.7 211 5.7±7.3‡ 211 53.3±29.1 210 8.4±26.4
Bottom 3 Quartiles 636 54.1±8.7 636 4.0±6.8 625 54.8±28.2 624 9.0±28.6
Sleep Efficiency (%)
Top Quartile 212 53.6±9.5 212 4.7±7.3 212 51.4±29.2* 212 9.2±28.3
Bottom 3 Quartiles 636 54.4±8.4 635 4.4±6.9 624 55.5±28.1 622 8.8±28.0
Arousal Index (#/h TST)
Top Quartile 211 53.7±8.7 211 4.5±6.8 209 53.5±27.3 208 7.5±28.1
Bottom 3 Quartiles 638 54.3±8.7 637 4.4±7.0 628 54.7±28.8 627 9.4±28.0
N1 Sleep (Min)
Top Quartile 211 54.0±8.9 211 4.6±7.2 210 55.4±28.0 208 10.3±25.6
Bottom 3 Quartiles 638 54.2±8.6 637 4.4±6.9 627 54.2±28.6 627 8.4±28.8
N1 Sleep (%)
Top Quartile 213 54.3±8.6 213 4.9±7.0 212 55.8±28.0 210 9.0±29.1
Bottom 3 Quartiles 636 54.1±8.7 635 4.3±7.0 625 54.0±28.6 625 8.9±27.7
N2 Sleep (Min)
Top Quartile 213 54.1±8.5 213 5.1±7.3* 211 54.8±29.8 210 8.8±26.8
Bottom 3 Quartiles 636 54.2±8.8 635 4.2±6.9 626 54.3±28.0 625 8.9±28.5
N2 Sleep (%)
Top Quartile 212 53.4±9.1 212 4.3±7.0 209 52.3±29.8 209 9.2±30.0
Bottom 3 Quartiles 637 54.4±8.5 636 4.5±7.0 628 55.1±27.9 626 8.8±27.3
N3 Sleep (Min)
Top Quartile 213 55.9±7.7‡ 213 4.9±6.7 208 55.7±27.2 207 12.0±28.9*
Bottom 3 Quartiles 636 53.6±8.9 635 4.3±7.1 629 54.0±28.8 628 7.9±27.7
N3 Sleep (%)
Top Quartile 212 55.9±7.8‡ 212 5.0±6.6 208 55.3±27.2 207 11.6±28.7*
Bottom 3 Quartiles 636 53.6±8.9 635 4.3±7.1 628 54.1±28.9 627 7.9±27.8
REM Sleep (Min)
Top Quartile 213 54.9±8.8 213 5.5±7.3* 211 55.8±29.2 211 11.0±27.7
Bottom 3 Quartiles 636 53.9±8.6 635 4.2±6.9 626 54.0±28.1 624 8.2±28.2
REM Sleep (%)
Top Quartile 214 54.7±8.8 214 5.3±7.3† 212 55.7±28.5 212 10.9±26.8
Bottom 3 Quartiles 635 54.0±8.6 634 4.1±6.9 625 54.0±28.4 623 8.2±28.4
Apnea Hypopnea Index (#/h)
Top Quartile 212 54.4±8.6 211 4.4±7.1 212 52.1±28.1 210 8.9±28.5
Bottom 3 Quartiles 637 53.6±8.8 637 4.3±6.7 625 55.2±28.4 625 8.9±27.9
% Time O2 Saturation < 85%
Top Quartile 212 52.9±8.8† 211 4.4±7.4 212 53.3±27.5 211 9.9±27.5
Bottom 3 Quartiles 639 54.6±8.6 637 4.4±6.9 625 54.8±28.7 624 8.6±28.3
Compliance with CPAP/Sham 
CPAP at 6 months, Hours)
Top Quartile 180 53.4±8.8 180 4.0±7.0 178 52.9±28.5 178 9.0±26.6
Bottom 3 Quartiles 645 54.4±8.6 644 4.6±6.9 635 54.7±28.4 633 8.7±28.3
Table 4. Six Month and Change After 6 Month Scores on the Buschke Selective Reminding and Symbol Digit Coding Tasks.
* p<0.10
p<0.05
p<0.01
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85% were associated with worse Buschke but not DSST scores 
at 6 months. For the DSST task, the current results differ some-
what from findings derived from the Sleep Heart Health Study 
in which performance on the composite variable “Procspeed”, 
a combination of  Digit Symbol Coding and Symbol Search, was 
negatively associated with oxygen desaturation24. Previous hu-
man studies specifically addressing the impact of  hypoxemia on 
memory in persons with OSA are sparse and conflicting. In a 
study of  50 OSA patients, nocturnal hypoxemia was associated 
with lower scores on some memory tasks25. 
However, in another study of  40 OSA patients, those 
with greater hypoxemia paradoxically performed better on as-
sessments of  memory26. Mechanistically, studies in animals 
indicate that hypoxemia can result in neuronal damage to the 
hippocampus and neocortex, areas of  the brain important for 
memory consolidation27. Thus, our results from a large dataset 
in humans provide some support to suggest that nocturnal hy-
poxemia is deleterious for memory, but additional human stud-
ies to specifically address this issue are needed.
There are some limitations to this study. First, assess-
ments of  memory were restricted to only the Buschke and the 
DSST. A broader spectrum of  tasks to evaluate memory perfor-
mance may have resulted in different findings. Second, all of  the 
participants in the study had OSA which may have influenced 
the results independent of  changes in sleep. Finally, our results 
must be considered preliminary and hypothesis generating. The 
analytic outcomes chosen were exploratory and derived post hoc; 
our hypothesis that memory is associated with increases in REM 
sleep and SWS was not an initial goal of  APPLES. In addition, 
no statistical corrections were made for multiple analytic out-
comes and hence there is the possibility of  increased Type 1 
error.  Nevertheless, strengths of  this analysis include the large 
number of  participants, long duration of  the intervention and 
use of  home-based polysomnography, with the latter avoiding 
the artificial environment of  a sleep laboratory.
In conclusion, CPAP produced long-standing improve-
ments in sleep duration, quality and architecture, but did not 
improve performance on a limited battery of  memory tasks. 
However, large changes in REM and N3 sleep as well as moder-
ate amounts of  nocturnal hypoxemia do impact memory.
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